Accordingly, we speculate that E2F1 may affect the progression and prognosis of various diseases such as asthma, malignant tumor through basal transcriptional regulation of human ADRB2 gene, and that E2F1 may become a new therapeutic target and prognostic marker. The gene discussed is E2F1; the disease is cancer.